Comparison of Computer-Guided Versus Standard Insulin Infusion Regimens in Patients With Diabetic Ketoacidosis
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background: This study was performed to investigate the efficacy of Glucommander (GM) (Glytec®), a computer-based algorithm versus standard (paper form-based) continuous insulin infusion (CII) in the treatment of patients with diabetic ketoacidosis (DKA). Methods: This was a retrospective multicenter study involving 2665 patients with DKA treated with either GM (n = 1750) or standard protocols (n = 915) across 34 institutions in the United States. GM estimates the rate of CII using an insulin sensitivity factor referred to as a “multiplier” that ranges between 0.01 and 0.03. Outcomes of interest were differences in time to resolve DKA (blood glucose [BG] <200 mg/dL and bicarbonate < 18 mmol/L) and number of hypoglycemic events defined as a BG <70 mg/dl. Results: Treatment with GM was associated with lower rates of hypoglycemia during the time of the insulin drip (12.9% vs 35%, P = .001), faster time to normalization of blood glucose (9.7 ± 8.9 vs 10.97 ± 10.2 hours, P = .0001) and resolution of metabolic acidosis (13.6 ± 11.8 vs 17.3 ± 19.6 hours, P = .0001), and shorter hospital length of stay (3.2 ± 2.9 vs 4.5 ± 4.8 days, P = .01) compared to standard care. Best treatment outcomes were achieved with an initial multiplier of 0.01 and a glucose target range between 120 and 180 mg/dl. Conclusion: The GM algorithm in DKA treatment resulted in lower rates of hypoglycemia and faster DKA resolution over standard paper-based algorithms. Prospective randomized clinical trials comparing the efficacy and cost of computer-based algorithms versus standard CII regimens are warranted.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“most hospitals use institutional-based, nurse-driven protocols, with several validated protocols published.1291–1293”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1292]
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Hyperglycemic crises in adult patients with diabetes
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009) · Diabetes Care · doi:10.2337/dc09-9032 · Cited by 2,062
Self-citationManagement of Hyperglycemic Crises in Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., Barrett, E. J., Kreisberg, R. A., Malone, J. I., & Wall, B. M. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.131 · Cited by 710
Self-citationJacobi, J., Bircher, N., Krinsley, J., Agus, M., Braithwaite, S. S., Deutschman, C., Freire, A. X., Geehan, D., Kohl, B., Nasraway, S. A., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182653269 · Cited by 571
Self-citationHypoglycemia and outcome in critically ill patients
Egi, M., Bellomo, R., Stachowski, E., French, C. J., Hart, G. K., Taori, G., Hegarty, C., & Bailey, M. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0394 · Cited by 432 · cited 6×
“The initial BG was significantly higher in the GM group but the time for resolution of DKA was faster with GM.”
BackgroundMethodInfluentialHyperglycemic Crises in Urban Blacks
Umpierrez, G. E. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.6.669 · Cited by 295
Self-citationHypoglycemia as a Predictor of Mortality in Hospitalized Elderly Patients
Kagansky, N., Levy, S., Rimon, E., Cojocaru, L., Fridman, A., Ozer, Z., & Knobler, H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.15.1825 · Cited by 231
Davidson, P. C., Steed, R. D., & Bode, B. W. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2418 · Cited by 230
Insulin Analogs Versus Human Insulin in the Treatment of Patients With Diabetic Ketoacidosis
Umpierrez, G. E., Jones, S., Smiley, D., Mulligan, P., Keyler, T., Temponi, A., Semakula, C., Umpierrez, D., Peng, L., Cerón, M., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0169 · Cited by 120 · cited 1×
“Typically, regular human insulin is the preferred intravenous insulin however, there have been studies demonstrating the use of analog insulin in DKA therapy.(9) There have been smaller retrospective studies in critically ill patients comparing nurse-driven computerized insulin infusion program and conventional paper-…”
Self-citationNewton, C. A., Smiley, D., Bode, B. W., Kitabchi, A. E., Davidson, P. C., Jacobs, S., Steed, R. D., Stentz, F., Peng, L., Mulligan, P., et al. (2010) · Journal of Hospital Medicine · doi:10.1002/jhm.816 · Cited by 84
Self-citation
Research works printed but not linked: 2
- Centers for Disease Control and Prevention, 2014, National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States
- 10.1001/archinte.1997.00440270117011 · doi:10.1001/archinte.1997.00440270117011 · Paper page
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationPasquel, F. J., Tsegka, K., Wang, H., Cardona, S., Galindo, R. J., Fayfman, M., Davis, G., Vellanki, P., Migdal, A., Gujral, U., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1168 · Cited by 161
Self-citationDavis, G. M., Faulds, E., Walker, T., Vigliotti, D., Rabinovich, M., Hester, J., Peng, L., McLean, B., Hannon, P., Poindexter, N., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2085 · Cited by 94
Self-citationDiabetes technology in the inpatient setting for management of hyperglycemia
Davis, G. M., Galindo, R. J., Migdal, A. L., & Umpierrez, G. E. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.11.002 · Cited by 62
Self-citationSly, B., Russell, A. W., & Sullivan, C. (2022) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2021.104596 · Cited by 36
Metadata
- Authors
- Ullal, J., Aloi, J. A., Reyes-Umpierrez, D., Pasquel, F. J., McFarland, R., Rabinovich, M., & Umpierrez, G. E.
- Affiliations
- Eastern Virginia Medical School (US)
- Wake Forest University Health Sciences (US)
- Emory University (US)
- Glytec, Greenville, SC, USA
- Grady Memorial Hospital (US)
- Corresponding author
- Ullal, Jagdeesh
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2018-01
- Volume
- 12
- Issue
- 1
- Pages
- 39-46
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC5762000
- OpenAlex
- W2781868661
- Cited by
- 49
- References
- 19
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 7 · 2023: 3 · 2022: 7 · 2021: 7 · 2020: 5 · 2019: 9 · 2018: 2
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetic ketoacidosis, continuous insulin infusion, insulin sensitivity factor, hypoglycemia, glycemic control, length of hospital stay
- MeSH terms
- Adult, Aged, Algorithms, Blood Glucose, Female, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Male, Middle Aged, Retrospective Studies, Diabetic Ketoacidosis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of Computer-Guided Versus Standard Insulin Infusion Regimens in Patients With Diabetic Ketoacidosis. https://app.cochat.ai/papers/10.1177/1932296817750899
- The paper
- Ullal, J., Aloi, J. A., Reyes-Umpierrez, D., Pasquel, F. J., McFarland, R., Rabinovich, M., & Umpierrez, G. E. (2018). Comparison of Computer-Guided Versus Standard Insulin Infusion Regimens in Patients With Diabetic Ketoacidosis. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296817750899
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.